Dark

CRNX
Crinetics Pharmaceuticals, Inc.
stock NASDAQ

At Close

Sep 26, 2025 3:59:54 PM EDT

45.90USD+27.905%(+10.01)10,218,170

0.00Bid 0.00Ask 0.00Spread

Pre-market

Sep 26, 2025 9:28:30 AM EDT

40.50USD+12.845%(+4.61)261,849

After-hours

Sep 26, 2025 4:56:30 PM EDT

45.85USD-0.120%(-0.05)33,207

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

4.30B

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Nov 6, 2025 (39d)

CRNX Stats

Avg. Vol. 10 Day

2,359,709

Avg. Vol. 30 Day

1,536,449

Employees

210

Market Cap

4,300,075,886

Shares Out.

94,175,994

On/Off Exchange

57%/43%

6 Month Beta

1.12

1 Year Beta

1.18

2 Year Beta

1.17

3 Year Beta

1.11

52 Week Low

24.10

52 Week High

62.53

SMA50

31.78

SMA200

34.92

1 Week

+35.41%

1 Month

+48.97%

3 Month

+52.40%

6 Month

+31.47%

1 Year

-10.03%

2 Year

+55.62%

5 Year

+210.19%

Profile

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.

CRNX Stock Summary

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) stock price today is $45.90, and today's volume is 10,218,170. CRNX is up 27.905% today. The 30 day average volume is 1,536,449. CRNX market cap is 4.30B with 94,175,994 shares outstanding.

.dark-mode .rcWxxd{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .rcWxxd{ color: #333333; background-color: white; border: 2px solid #333333; }CRNXCrinetics Pharmaceuticals, Inc.stock NASDAQ

CRNX Stock Summary

CRNX
Crinetics Pharmaceuticals, Inc.
stock NASDAQ